Phio Pharmaceuticals Corp. (PHIO)
1.15
-0.03
(-2.54%)
USD |
NASDAQ |
Aug 24, 16:00
1.15
0.00 (0.00%)
After-Hours: 20:00
Phio Pharmaceuticals Total Liabilities (Quarterly) : 1.705M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.705M |
| March 31, 2026 | 0.95M |
| December 31, 2025 | 1.34M |
| September 30, 2025 | 1.666M |
| June 30, 2025 | 1.206M |
| March 31, 2025 | 1.27M |
| December 31, 2024 | 1.015M |
| September 30, 2024 | 0.919M |
| June 30, 2024 | 1.523M |
| March 31, 2024 | 1.249M |
| December 31, 2023 | 1.634M |
| September 30, 2023 | 2.326M |
| June 30, 2023 | 2.392M |
| March 31, 2023 | 2.396M |
| December 31, 2022 | 1.974M |
| September 30, 2022 | 2.264M |
| June 30, 2022 | 3.141M |
| March 31, 2022 | 2.711M |
| December 31, 2021 | 3.238M |
| September 30, 2021 | 2.697M |
| June 30, 2021 | 2.812M |
| March 31, 2021 | 2.456M |
| December 31, 2020 | 2.722M |
| September 30, 2020 | 2.786M |
| June 30, 2020 | 2.478M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.32M |
| December 31, 2019 | 2.291M |
| September 30, 2019 | 2.474M |
| June 30, 2019 | 2.401M |
| March 31, 2019 | 2.016M |
| December 31, 2018 | 1.744M |
| September 30, 2018 | 2.059M |
| June 30, 2018 | 2.759M |
| March 31, 2018 | 2.523M |
| December 31, 2017 | 2.265M |
| September 30, 2017 | 2.603M |
| June 30, 2017 | 2.454M |
| March 31, 2017 | 2.265M |
| December 31, 2016 | 2.542M |
| September 30, 2016 | 1.865M |
| June 30, 2016 | 1.553M |
| March 31, 2016 | 1.221M |
| December 31, 2015 | 2.269M |
| September 30, 2015 | 1.665M |
| June 30, 2015 | 1.822M |
| March 31, 2015 | 1.556M |
| December 31, 2014 | 1.334M |
| September 30, 2014 | 1.156M |
| June 30, 2014 | 1.053M |
| March 31, 2014 | 1.39M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Imunon, Inc. | 10.80M |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.31M |
| Shareholders Equity (Quarterly) | 12.60M |
| Current Ratio | 8.386 |